While earlier studies reported reduced expression of ITGB4 in both prostatic intraepithelial neoplasms and invasive prostate carcinomas [51], later publications are available showing overexpression of ITGB4 in more aggressive prostate carcinomas [52]. This evidence concerns the gene ITGB4 and prostate carcinoma.